Literature DB >> 27878584

Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study.

Hyun Gi Kim1, Na-Young Shin2,3, Yunjin Bak4, Kyung Ran Kim5, Young-Chul Jung5, Kyunghwa Han6, Seung-Koo Lee6, Soo Mee Lim4.   

Abstract

OBJECTIVES: To characterize the pattern of altered intrinsic brain activity in gastric cancer patients after chemotherapy (CTx).
METHODS: Patients before and after CTx (n = 14) and control subjects (n = 11) underwent resting-state functional MRI (rsfMRI) at baseline and 3 months after CTx. Regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF), and fractional ALFF (fALFF) were calculated and compared between the groups using the two-sample t test. Correlation analysis was also performed between rsfMRI values (i.e., ReHo, ALFF, and fALFF) and neuropsychological test results.
RESULTS: Patients showed poor performance in verbal memory and executive function and decreased rsfMRI values in the frontal areas even before CTx and showed decreased attention/working memory and executive function after CTx compared to the control subjects. In direct comparison of values before and after CTx, there were no significant differences in neuropsychological test scores, but decreased rsfMRI values were observed at the frontal lobes and right cerebellar region. Among rsfMRI values, lower ALFF in the left inferior frontal gyrus was significantly associated with poor performance of the executive function test.
CONCLUSIONS: We observed decreased attention/working memory and executive function that corresponded to the decline of frontal region activation in gastric cancer patients who underwent CTx. KEY POINTS: • Intrinsic brain activity of gastric cancer patients after chemotherapy was described. • Brain activity and neuropsychological test results were correlated. • Working memory and executive function decreased after chemotherapy. • Decreased cognitive function corresponded to decreased activation of the frontal region.

Entities:  

Keywords:  Brain; Cancer chemotherapy agents; Cognitive function; Functional magnetic resonance imaging; Gastric cancer

Mesh:

Substances:

Year:  2016        PMID: 27878584     DOI: 10.1007/s00330-016-4578-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  51 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Regional homogeneity approach to fMRI data analysis.

Authors:  Yufeng Zang; Tianzi Jiang; Yingli Lu; Yong He; Lixia Tian
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

3.  The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

Authors:  V Shilling; V Jenkins; R Morris; G Deutsch; D Bloomfield
Journal:  Breast       Date:  2005-04       Impact factor: 4.380

Review 4.  Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis.

Authors:  Michelle Monje; Jörg Dietrich
Journal:  Behav Brain Res       Date:  2011-05-23       Impact factor: 3.332

5.  Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.

Authors:  Kerstin Hermelink; Michael Untch; Michael P Lux; Rolf Kreienberg; Thomas Beck; Ingo Bauerfeind; Karin Münzel
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

Review 6.  Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; Susana Cardoso; Cristina Carvalho; Maria S Santos; Catarina R Oliveira; Paula I Moreira
Journal:  Curr Aging Sci       Date:  2010-07

7.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Pretreatment worry and neurocognitive responses in women with breast cancer.

Authors:  Marc G Berman; Mary K Askren; Misook Jung; Barbara Therrien; Scott Peltier; Douglas C Noll; Min Zhang; Lynn Ossher; Daniel F Hayes; Patricia A Reuter-Lorenz; Bernadine Cimprich
Journal:  Health Psychol       Date:  2013-08-05       Impact factor: 4.267

9.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006

10.  Altered functional connectivity in an aged rat model of postoperative cognitive dysfunction: a study using resting-state functional MRI.

Authors:  Peng Xie; Tian Yu; Xiaoyun Fu; Ye Tu; Yan Zou; Su Lui; Xuna Zhao; Xiaoqi Huang; Graham J Kemp; Qiyong Gong
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more
  9 in total

Review 1.  Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

Authors:  M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

2.  Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: a resting state fMRI study.

Authors:  Behroze A Vachha; Suril Gohel; James C Root; Maria Kryza-Lacombe; Martee L Hensley; Denise D Correa
Journal:  Brain Imaging Behav       Date:  2021-08-18       Impact factor: 3.224

3.  Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study.

Authors:  Bihong T Chen; Taihao Jin; Sunita K Patel; Ningrong Ye; Huiyan Ma; Chi Wah Wong; Russell C Rockne; James C Root; Andrew J Saykin; Tim A Ahles; Andrei I Holodny; Neal Prakash; Joanne Mortimer; James Waisman; Yuan Yuan; Daneng Li; Mina S Sedrak; Jessica Vazquez; Vani Katheria; William Dale
Journal:  Breast Cancer Res Treat       Date:  2019-04-13       Impact factor: 4.872

Review 4.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

5.  Altered Spontaneous Brain Activity in Patients With Idiopathic Trigeminal Neuralgia: A Resting-state Functional MRI Study.

Authors:  Jie Yuan; Song Cao; Yue Huang; Yi Zhang; Peng Xie; Yu Zhang; Bao Fu; Tijiang Zhang; Ganjun Song; Tian Yu; Mazhong Zhang
Journal:  Clin J Pain       Date:  2018-07       Impact factor: 3.442

6.  Altered intrinsic local activity and cognitive dysfunction in HIV patients: A resting-state fMRI study.

Authors:  Yunjin Bak; Sunyoung Jun; Jun Yong Choi; Youngjoon Lee; Seung-Koo Lee; Sanghoon Han; Na-Young Shin
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

7.  Comparing the Impact of Laparoscopic Sleeve Gastrectomy and Gastric Cancer Surgery on Resting-State Brain Activity and Functional Connectivity.

Authors:  Yong Gu; Guanya Li; Jia Wang; Karen M von Deneen; Kaichun Wu; Yan Yang; Junjun She; Gang Ji; Yongzhan Nie; Guangbin Cui; Yi Zhang; Shuixiang He
Journal:  Front Neurosci       Date:  2020-11-26       Impact factor: 4.677

8.  Chemotherapy-induced functional brain abnormality in colorectal cancer patients: a resting-state functional magnetic resonance imaging study.

Authors:  Siwen Liu; Yesong Guo; Jie Ni; Na Yin; Chenchen Li; Xuan Pan; Rong Ma; Jianzhong Wu; Shengwei Li; Xiaoyou Li
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

9.  Altered Dynamic Neural Activity in the Default Mode Network in Lung Cancer Patients After Chemotherapy.

Authors:  Jia You; Lanyue Hu; Yujie Zhang; Feifei Chen; Xindao Yin; Mingxu Jin; Yu-Chen Chen
Journal:  Med Sci Monit       Date:  2020-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.